ArticleCell death & disease2021

MIEF2 reprograms lipid metabolism to drive progression of ovarian cancer through ROS/AKT/mTOR signaling pathway.

Shuhua Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.